President Trump has made “no final decision” on military action in Syria after meeting with his national security team this afternoon, the White House says.

Expand chart
Data: Conflict Monitor by IHS Markit as of April 9; Map: Lazaro Gamio/Axios

Why it matters: U.S. allies and adversaries alike are waiting for a signal from Trump, who yesterday warned that missiles “will be coming” but has avoided making similar statements today. He tweeted that the response could come “very soon or not so soon at all” and told reporters “we’ll see what happens.”

The latest: The U.S. has blood and urine samples from Saturday’s attack in Syria which “have tested positive for chemical weapons,” NBC News reports, citing officials who said “intelligence from the U.S. and other countries, including images” indicates the Assad regime was responsible

What’s next: Trump just spoke with U.K. Prime Minister May and will also speak with French President Macron this evening. Both countries appeared to move closer to military action today...

  • In the U.K.: May’s cabinet unanimously agreed it is “highly likely that the regime is responsible for Saturday’s attack” and “vital that the use of chemical weapons did not go unchallenged.” The cabinet backed an “international response,” signaling the U.K. could take part in strikes.
  • In France: Macron said, “we have proof that last week chemical weapons, at least chlorine, were used by the regime of Bashar Al Assad.” Macron, who vowed last year that the use of chemical weapons "would result in reprisal and an immediate response,” said he would decide what action to take “in due course.”
  • In Germany: Chancellor Angela Merkel ruled out military action but said Germany supports “everything done to send a signal that this use of chemical weapons is not acceptable.”

Worth noting: Saudi Crown Prince Mohammed bin Salman said Tuesday that the kingdom "will be present" in the international response "if our alliance with our partners requires it.”

Go deeper: Trump's options for striking in Syria.

Go deeper

8 mins ago - Health

If Trump replaces Ginsburg, the ACA really is at risk

Illustration: Aïda Amer/Axios

The Supreme Court vacancy created by Ruth Bader Ginsburg’s death leaves the Affordable Care Act in much greater jeopardy than it was just a few days ago.

The big picture: Conventional wisdom had held that Chief Justice John Roberts would likely join with the court’s liberals to save the ACA once again. But if President Trump is able to fill Ginsburg’s former seat, Roberts’ vote alone wouldn’t be enough to do the trick, and the law — or big sections of it — is more likely to be struck down.

Ben Geman, author of Generate
13 mins ago - Energy & Environment

Nikola founder steps aside amid allegations of fraud

Illustration: Lazaro Gamio/Axios

Nikola announced Monday that executive chairman Trevor Milton, who is also the company's founder, is out as the electric and fuel cell truck startup reportedly faces federal inquiries into a short-seller's allegations of inaccurate or misleading statements.

Why it matters: It's the latest move in a head-spinning series of events for Nikola.

College students give failing grade on return to campus

Illustration: Sarah Grillo/Axios

College students are learning less, partying less and a majority say the decision to return to campus was a bad decision, according to a new College Reaction/Axios poll.

Why it matters: The enthusiasm to forge something resembling a college experience has dissipated as online learning, lockdowns and a diminished social life has set in.